DE69029135T2 - Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel - Google Patents

Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel

Info

Publication number
DE69029135T2
DE69029135T2 DE69029135T DE69029135T DE69029135T2 DE 69029135 T2 DE69029135 T2 DE 69029135T2 DE 69029135 T DE69029135 T DE 69029135T DE 69029135 T DE69029135 T DE 69029135T DE 69029135 T2 DE69029135 T2 DE 69029135T2
Authority
DE
Germany
Prior art keywords
retrovirus
particles produced
core structures
producing core
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69029135T
Other languages
English (en)
Other versions
DE69029135D1 (de
Inventor
Hiroshi Shibuta
Tatsuo Shioda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zeon Co Ltd filed Critical Nippon Zeon Co Ltd
Publication of DE69029135D1 publication Critical patent/DE69029135D1/de
Application granted granted Critical
Publication of DE69029135T2 publication Critical patent/DE69029135T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69029135T 1989-05-30 1990-05-29 Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel Expired - Fee Related DE69029135T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13686289 1989-05-30
PCT/JP1990/000689 WO1990015133A1 (en) 1989-05-30 1990-05-29 Method of producing core structure of retro virus and particle produced thereby

Publications (2)

Publication Number Publication Date
DE69029135D1 DE69029135D1 (de) 1996-12-19
DE69029135T2 true DE69029135T2 (de) 1997-05-28

Family

ID=15185257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69029135T Expired - Fee Related DE69029135T2 (de) 1989-05-30 1990-05-29 Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel

Country Status (3)

Country Link
EP (1) EP0474868B1 (de)
DE (1) DE69029135T2 (de)
WO (1) WO1990015133A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741358B1 (fr) * 1995-11-17 1998-01-02 Centre Nat Rech Scient Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn
GB2345062B (en) * 1997-12-22 2001-07-25 Oxford Biomedica Ltd Retroviral vectors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2708046B2 (ja) * 1986-11-01 1998-02-04 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 融合タンパク質および粒子
DE3854857T2 (de) * 1987-06-10 1996-08-22 Immune Response Corp Inc Verhütung und behandlung einer retrovirenkrankheit

Also Published As

Publication number Publication date
DE69029135D1 (de) 1996-12-19
EP0474868A1 (de) 1992-03-18
EP0474868A4 (en) 1992-09-09
EP0474868B1 (de) 1996-11-13
JPH0372874A (ja) 1991-03-28
WO1990015133A1 (en) 1990-12-13

Similar Documents

Publication Publication Date Title
DE69414315D1 (de) Verfahren zur Herstellung von Kapseln sowie dadurch erhaltene Kapseln
DE3868044D1 (de) Aufblasbare faltstruktur und verfahren zur herstellung von faltstrukturen.
DE69022056D1 (de) Verfahren zur herstellung einer mischung von sacchariden.
DE69302907T2 (de) Verfahren zur herstellung von feuchtigkeitsbeständigem aluminiumnitridpulver und dadurch hergestelltes pulver
DE19581787T1 (de) Verfahren zur Herstellung von Mikrokügelchen und dadurch hergestellte Mikrokügelchen
DE59002992D1 (de) Hotelkanne und Verfahren zur Herstellung derselben.
DE69415985T2 (de) Verfahren zur herstellung einer wässrigen gelartigen zusammensetzung und so erhaltene zusammensetzung
DE3780676T2 (de) Verfahren zur modifizierung von oberflaechen und anwendung dieser methode zur herstellung von geschichteten strukturen.
DE69025908D1 (de) Leitfähige struktur bildende zusammensetzung und verfahren zur herstellung derselben
DE3751992D1 (de) Cordierit-Zusammensetzung und Verfahren zur Herstellung
DE59010245D1 (de) Strahlungsempfindliches Gemisch und Verfahren zur Herstellung von Reliefstrukturen
DE68906986T2 (de) Verfahren zur herstellung von chf20chfcf3 und chf20chclcf3 und dabei verwendete zwischenverbindungen.
DE69330525D1 (de) Verfahren zur herstellung von kugelförmigen teilchen
DE69029135T2 (de) Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel
DE59409580D1 (de) Photopolymerisierbares Gemisch und Verfahren zur Herstellung von Lötstopmasken
DE59010681D1 (de) Strahlungsempfindliches Gemisch und Verfahren zur Herstellung von Reliefstrukturen
DE69033758D1 (de) Verfahren zur herstellung von norcamphandikarbonitrilen
DE3688854D1 (de) Verfahren zur herstellung von polythiobisphenolen und verfahren zur herstellung von mercaptophenolen durch hydrogenolyse der polythiobisphenole.
DE3751769T2 (de) Photoempfindliche Kunststoffzusammensetzung und Verfahren zur Herstellung von Feinstrukturen mit dieser Zusammensetzung
DE3865484D1 (de) Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid.
PT86489A (de) Verfahren zur herstellung von lipophilen aminosaeurederivaten sowie lipophile aminosaeurederivate
ATA247687A (de) Verfahren zur herstellung von 5-aryliden- und -alkylidensubstituierten hydantoinen
DE69027707T2 (de) Photoempfindliche Zusammensetzung und Verfahren zur Herstellung von Mustern unter Verwendung dieser Zusammensetzung
ATA17288A (de) Verfahren und vorrichtung zur herstellung von zement aus zementrohmehl
DE68912664D1 (de) Verfahren und Vorrichtung zur Herstellung von Feinstrukturen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee